Gabriela Plesa

13.1k citations

45 papers · 4.5k · 6 hit papers · h-index 26

Impact in

Oncology top 0.5%
- CAR-T cell therapy research
Virology top 1%
- HIV Research and Treatment

Papers in

Oncology 35
- CAR-T cell therapy research 35
- Cancer Immunotherapy and Biomarkers 5
Immunology 14
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 6
- Immunotherapy and Immune Responses 5

Co-authors: Carl H. June (31 shared papers)Bruce L. Levine (19 shared papers)Michael Kalos (3 shared papers)Gregory L. Beatty (8 shared papers)Drew A. Torigian (4 shared papers)Michael C. Soulen (3 shared papers)James L. Riley (8 shared papers)Wei‐Ting Hwang (7 shared papers)
Journals: Journal of Clinical Oncology (7 papers)Molecular Therapy (5 papers)Blood (4 papers)Science Translational Medicine (3 papers)Cytotherapy (3 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Gabriela Plesa

43 papers receiving 4.4k citations

Gabriela Plesa's Hit Papers

6 papers align trajectories log scale

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells 2023 · 104 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Immunity
2022 Nature Biomedical Engineering
2018 Gastroenterology
2014 New England Journal of Medicine
2013 Cancer Immunology Research
2012 Science Translational Medicine

Peers

Countries citing papers authored by Gabriela Plesa

Since Specialization

Citations

This map shows the geographic impact of Gabriela Plesa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriela Plesa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriela Plesa more than expected).

Fields of papers citing papers by Gabriela Plesa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriela Plesa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriela Plesa. The network helps show where Gabriela Plesa may publish in the future.

Co-authors

The 25 scholars most cited alongside Gabriela Plesa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gabriela Plesa Line = papers co-authored together Gabriela Plesa links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV New England Journal of Medicine ·Pablo Tebas, David Stein, Winson W. Tang, Ian Frank, Shelley Q. Wang, Gary Lee, S. Kaye Spratt, Richard Surosky, Martin Giedlin, Geoff Nichol, Michael C. Holmes, Philip D. Gregory, Dale Ando, Michael Kalos, Ronald G. Collman, Gwendolyn Binder-Scholl, Gabriela Plesa, Wei‐Ting Hwang, Bruce L. Levine, Carl H. June Hit paper breakdown →	2014	973
2	Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies Cancer Immunology Research ·Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus, Drew A. Torigian, Michael C. Soulen, Gabriela Plesa, Anne Chew, Yangbing Zhao, Bruce L. Levine, Steven Μ. Albelda, Michael Kalos, Carl H. June Hit paper breakdown →	2013	693
3	Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells Science Translational Medicine ·John Scholler, Troy Brady, Gwendolyn Binder-Scholl, Wei‐Ting Hwang, Gabriela Plesa, Kristen Hege, Ashley N. Vogel, Michael Kalos, James L. Riley, Steven G. Deeks, Ronald T. Mitsuyasu, Wendy B. Bernstein, Naomi Aronson, Bruce L. Levine, Frederic D. Bushman, Carl H. June Hit paper breakdown →	2012	502
4	Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial Gastroenterology ·Gregory L. Beatty, Mark H. O’Hara, Simon F. Lacey, Drew A. Torigian, Farzana Nazimuddin, Fang Chen, Irina Kulikovskaya, Michael C. Soulen, Maureen McGarvey, Anne Marie Nelson, Whitney L. Gladney, Bruce L. Levine, J. Joseph Melenhorst, Gabriela Plesa, Carl H. June Hit paper breakdown →	2018	379
5	Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers Molecular Therapy ·Andrew R. Haas, János L. Tanyi, Mark H. O’Hara, Whitney L. Gladney, Simon F. Lacey, Drew A. Torigian, Michael C. Soulen, Lifeng Tian, Maureen McGarvey, Anne Marie Nelson, Caitlin S. Farabaugh, Edmund K. Moon, Bruce L. Levine, J. Joseph Melenhorst, Gabriela Plesa, Carl H. June, Steven Μ. Albelda, Gregory L. Beatty	2019	278
6	The Inducible Costimulator (ICOS) Is Critical for the Development of Human T _H 17 Cells Science Translational Medicine ·Chrystal M. Paulos, Carmine Carpenito, Gabriela Plesa, Megan M. Suhoski, Angel Varela‐Rohena, Tatiana N. Golovina, Richard G. Carroll, James L. Riley, Carl H. June	2010	204
7	Rapid manufacturing of non-activated potent CAR T cells Nature Biomedical Engineering ·Saba Ghassemi, Joseph S. Durgin, Selene Nuñez-Cruz, Jai Patel, John Leferovich, Marilia Rita Pinzone, Feng Shen, Katherine D. Cummins, Gabriela Plesa, Adrian Cantu, Shantan Reddy, Frederic D. Bushman, Saar Gill, Una O’Doherty, Roddy S. O’Connor, Michael C. Milone Hit paper breakdown →	2022	184
8	Steric Shielding of Surface Epitopes and Impaired Immune Recognition Induced by the Ebola Virus Glycoprotein PLoS Pathogens ·Joseph R. Francica, Angel Varela‐Rohena, Andrew Medvec, Gabriela Plesa, James L. Riley, Paul Bates	2010	120
9	Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells Immunity ·Sangya Agarwal, M. Ángela Aznar, Andrew J. Rech, Charly R. Good, Shunichiro Kuramitsu, Tong Da, Mercy Gohil, Linhui Chen, Seok-Jae Albert Hong, Pranali Ravikumar, Austin K. Rennels, January Salas-McKee, Weimin Kong, Marco Ruella, Megan M. Davis, Gabriela Plesa, Joseph A. Fraietta, David L. Porter, Regina M. Young, Carl H. June Hit paper breakdown →	2023	104
10	Efficient Clinical Scale Gene Modification via Zinc Finger Nuclease–Targeted Disruption of the HIV Co-receptor CCR5 Human Gene Therapy ·Dawn Maier, Andrea Brennan, Shuguang Jiang, Gwendolyn Binder-Scholl, Gary Lee, Gabriela Plesa, Zhaohui Zheng, Julio Cotte, Carmine Carpenito, Travis Wood, S. Kaye Spratt, Dale Ando, Philip D. Gregory, Michael C. Holmes, Elena Pérez, James L. Riley, Richard G. Carroll, Carl H. June, Bruce L. Levine	2013	91
11	Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients Molecular Therapy ·Katherine T. Marcucci, Julie K. Jadlowsky, Wei‐Ting Hwang, Megan Suhoski-Davis, Vanessa Gonzalez, Irina Kulikovskaya, Minnal Gupta, Simon F. Lacey, Gabriela Plesa, Anne Chew, J. Joseph Melenhorst, Bruce L. Levine, Carl H. June	2017	91
12	Engineered T cells for cancer therapy Cancer Immunology Immunotherapy ·Carl H. June, Marcela V. Maus, Gabriela Plesa, Laura A. Johnson, Yangbing Zhao, Bruce L. Levine, Stephan A. Grupp, David Porter	2014	87
13	BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion Science Translational Medicine ·In-Young Jung, Vivek Narayan, Sierra McDonald, Andrew J. Rech, Robert L. Bartoszek, Gwanui Hong, Megan M. Davis, Jun Xu, Alina C. Boesteanu, Julie S. Barber-Rotenberg, Gabriela Plesa, Simon F. Lacey, Julie K. Jadlowsky, Donald L. Siegel, Dana M. Hammill, Park F. Cho-Park, Shelley L. Berger, Naomi B. Haas, Joseph A. Fraietta	2022	82
14	Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T Cells Journal of Immunotherapy ·János L. Tanyi, Caitlin Stashwick, Gabriela Plesa, Mark A. Morgan, David L. Porter, Marcela V. Maus, Carl H. June	2017	56
15	TCR affinity and specificity requirements for human regulatory T-cell function Blood ·Gabriela Plesa, Lingjie Zheng, Andrew Medvec, Caleph B. Wilson, Camila Robles-Oteíza, Nathaniel Liddy, Alan Bennett, Jessie Gavarret, Annelise Vuidepot, Yangbing Zhao, Bruce R. Blazar, Bent K. Jakobsen, James L. Riley	2012	48
16	Safety and antitumor activity of chimeric antigen receptor modified T cells in patients with chemotherapy refractory metastatic pancreatic cancer. Journal of Clinical Oncology ·Gregory L. Beatty, Mark H. O’Hara, Anne Marie Nelson, Maureen McGarvey, Drew A. Torigian, Simon F. Lacey, Jan J. Melenhorst, Bruce L. Levine, Gabriela Plesa, Carl H. June	2015	45
17	Addition of Deoxynucleosides Enhances Human Immunodeficiency Virus Type 1 Integration and 2LTR Formation in Resting CD4⁺T Cells Journal of Virology ·Gabriela Plesa, Jihong Dai, Cliff Baytop, James L. Riley, Carl H. June, Una O’Doherty	2007	44
18	CRISPR/Cas9-based genome editing in the era of CAR T cell immunotherapy Human Vaccines & Immunotherapeutics ·January Salas-McKee, Weimin Kong, Whitney L. Gladney, Julie K. Jadlowsky, Gabriela Plesa, Megan M. Davis, Joseph A. Fraietta	2019	43
19	Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer Molecular Therapy ·Andrew H. Ko, Alexander C. Jordan, Evan Tooker, Simon F. Lacey, Renee B. Chang, Yan Li, Alan P. Venook, Margaret A. Tempero, Lloyd E. Damon, Lawrence Fong, Mark H. O’Hara, Bruce L. Levine, J. Joseph Melenhorst, Gabriela Plesa, Carl H. June, Gregory L. Beatty	2020	42
20	Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors Cell Reports Medicine ·In-Young Jung, Estela Noguera-Ortega, Robert L. Bartoszek, Sierra M. Collins, Erik F. Williams, Megan M. Davis, Julie K. Jadlowsky, Gabriela Plesa, Donald L. Siegel, Anne Chew, Bruce L. Levine, Shelley L. Berger, Edmund K. Moon, Steven Μ. Albelda, Joseph A. Fraietta	2023	36

About Gabriela Plesa

Gabriela Plesa is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Virology, having authored 45 papers that have together received 4.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (35 papers), Virus-based gene therapy research (10 papers), Immune Cell Function and Interaction (9 papers), CRISPR and Genetic Engineering (6 papers), T-cell and B-cell Immunology (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and HIV Research and Treatment (4 papers). The work is most often cited by research in Oncology (2.9k citations), Virology (449 citations), Immunology (1.4k citations), Business and International Management (119 citations) and Genetics (1.3k citations). Gabriela Plesa has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Carl H. June, Bruce L. Levine, Michael Kalos, Gregory L. Beatty, Drew A. Torigian, Michael C. Soulen, James L. Riley, Wei‐Ting Hwang, Gwendolyn Binder-Scholl and Marcela V. Maus. Their work appears in journals such as Journal of Clinical Oncology, Molecular Therapy, Blood, Science Translational Medicine and Cytotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Gabriela Plesa

Impact in

Papers in i

In The Last Decade

Gabriela Plesa

Gabriela Plesa's Hit Papers

Peers

Countries citing papers authored by Gabriela Plesa

Fields of papers citing papers by Gabriela Plesa

All Works

About Gabriela Plesa

Explore authors with similar magnitude of impact

Papers in